Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
02 2019
Historique:
received: 30 05 2018
accepted: 25 10 2018
pubmed: 21 11 2018
medline: 25 7 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

Adipose tissue insulin resistance is one of the pathophysiological components of type 2 diabetes. Herein we investigated: A total of 205 youth had fasting glucose, insulin, FFA, Adipose-IR, body composition, visceral adipose tissue (VAT), leptin, and adiponectin evaluated. Adipose-IR was 2.2-fold higher in obese NGT, 4.3-fold higher in IGT, and 4.6-fold higher in type 2 diabetes compared with that in normal-weight peers (all Adipose-IR is a simple surrogate estimate that reflects pathophysiological alterations in adipose tissue insulin sensitivity in youth, with progressive deterioration from normal weight to obese and from NGT to IGT to type 2 diabetes. Adipose-IR can be applied in large-scale epidemiological/observational studies of the natural history of youth-onset type 2 diabetes and its progression or reversal with intervention strategies.

Identifiants

pubmed: 30455334
pii: dc18-1178
doi: 10.2337/dc18-1178
pmc: PMC6341282
doi:

Substances chimiques

Blood Glucose 0
Insulin 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Pagination

265-272

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000005
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024153
Pays : United States
Organisme : NICHD NIH HHS
ID : K24 HD001357
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007052
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD027503
Pays : United States

Informations de copyright

© 2018 by the American Diabetes Association.

Références

Diabetes. 2006 May;55(5):1430-5
pubmed: 16644701
J Clin Invest. 1989 Jul;84(1):205-13
pubmed: 2661589
J Clin Endocrinol Metab. 2011 Jul;96(7):2136-45
pubmed: 21508130
Diabetes Care. 2014 Jan;37 Suppl 1:S81-90
pubmed: 24357215
Nutr Rev. 1981 Feb;39(2):43-55
pubmed: 7010232
Diabetes. 2017 Dec;66(12):3085-3090
pubmed: 28887312
Horm Metab Res. 2001 Jul;33(7):432-8
pubmed: 11507682
Obesity (Silver Spring). 2008 May;16(5):1066-71
pubmed: 18356853
J Clin Endocrinol Metab. 2016 Jun;101(6):2423-31
pubmed: 27054297
Diabetes. 1999 Oct;48(10):2039-44
pubmed: 10512371
J Clin Endocrinol Metab. 2013 May;98(5):2062-9
pubmed: 23526462
J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
pubmed: 15181022
Diabetes Care. 2010 Mar;33(3):632-8
pubmed: 20028940
Br J Radiol. 2012 Oct;85(1018):e826-30
pubmed: 22514099
Diabetes Care. 2013 Jun;36(6):1607-12
pubmed: 23275361
Diabetes. 2013 Aug;62(8):2917-22
pubmed: 23557704
Diabetes. 2002 May;51(5):1493-8
pubmed: 11978647
Int J Obes (Lond). 2017 Aug;41(8):1288-1294
pubmed: 28465607
Diabetes Care. 2018 Aug;41(8):1696-1706
pubmed: 29941497
Diabetes Care. 2007 Jun;30(6):1544-8
pubmed: 17384342
Diabetes Care. 2010 Sep;33(9):2024-30
pubmed: 20805276
Diabetes Care. 2018 Aug;41(8):1707-1716
pubmed: 29941498
Clin Sci (Lond). 2016 Oct 1;130(19):1753-62
pubmed: 27458255
N Engl J Med. 2012 Jun 14;366(24):2247-56
pubmed: 22540912
Diabetes Care. 2011 Sep;34(9):2033-40
pubmed: 21750275
Pediatr Diabetes. 2015 Dec;16(8):640-3
pubmed: 25385555
Am J Physiol Endocrinol Metab. 2011 Feb;300(2):E255-62
pubmed: 21119027
Pediatr Diabetes. 2011 May;12(3 Pt 2):250-7
pubmed: 21129140
Acta Diabetol. 2008 Sep;45(3):147-50
pubmed: 18357404
Diabetes. 2009 Apr;58(4):773-95
pubmed: 19336687
J Investig Med. 2016 Jun;64(5):989-91
pubmed: 27073214
Pediatr Obes. 2014 Oct;9(5):373-80
pubmed: 23861170
Diabetes. 2009 Mar;58(3):738-44
pubmed: 19073767
Pediatr Diabetes. 2018 Mar;19(2):205-211
pubmed: 28726334
Diabetes Care. 2009 Jan;32(1):100-5
pubmed: 18835946
Diabetes. 2017 Apr;66(4):815-822
pubmed: 28052966
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1193-1199
pubmed: 28323973
Diabetologia. 2002 Sep;45(9):1201-10
pubmed: 12242452

Auteurs

Joon Young Kim (JY)

Center for Pediatric Research in Obesity and Metabolism, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.
Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Fida Bacha (F)

Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX.

Hala Tfayli (H)

Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Sara F Michaliszyn (SF)

Department of Kinesiology and Sport Science, Youngstown State University, Youngstown, OH.

Shahwar Yousuf (S)

Center for Pediatric Research in Obesity and Metabolism, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.

Silva Arslanian (S)

Center for Pediatric Research in Obesity and Metabolism, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA silva.arslanian@chp.edu.
Division of Pediatric Endocrinology, Diabetes, and Metabolism, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH